Clarus Securities Weighs in on Aphria Inc’s Q3 2018 Earnings (APH)

Aphria Inc (TSE:APH) – Stock analysts at Clarus Securities issued their Q3 2018 earnings per share estimates for Aphria in a research report issued to clients and investors on Thursday. Clarus Securities analyst N. Atkinson expects that the company will post earnings per share of $0.01 for the quarter. Clarus Securities also issued estimates for Aphria’s FY2018 earnings at $0.15 EPS and FY2020 earnings at $1.60 EPS.

A number of other research analysts have also weighed in on APH. Canaccord Genuity set a C$23.00 target price on Aphria and gave the stock a “speculative buy” rating in a report on Thursday. Pi Financial boosted their target price on Aphria from C$14.00 to C$25.00 in a report on Thursday.

Aphria (TSE APH) traded down C$2.53 during mid-day trading on Friday, hitting C$18.02. The company had a trading volume of 11,206,600 shares, compared to its average volume of 5,490,000. The firm has a market cap of $2,730.00, a price-to-earnings ratio of 106.00 and a beta of -1.97. Aphria has a 1-year low of C$4.55 and a 1-year high of C$24.75.

ILLEGAL ACTIVITY NOTICE: “Clarus Securities Weighs in on Aphria Inc’s Q3 2018 Earnings (APH)” was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this piece of content can be viewed at

Aphria Company Profile

Aphria Inc produces, supplies, and sells medical cannabis in Canada. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders.

Earnings History and Estimates for Aphria (TSE:APH)

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit